Cheap, accessible, and powerful semaglutide is changing India’s weight-loss and diabetes landscape. But as prices crash and access expands, the risks also increase, ranging from misuse to side effects and fake drugs. Is this India’s next big healthcare breakthrough, or a crisis in the making? Watch as we break down the promise, the market shift, and the fine line between treatment and trend. #weightlossdrugs #semaglutide #diabetes Important Playlists National News: https://www.youtube.com/playlist?list=PLK5e1a2965YXb9Oh62yur4MRCdRLL6gCt Business News: https://www.youtube.com/playlist?list=PLK5e1a2965YVXM88oXiuA1JMLZtODGP1y World News: https://www.youtube.com/playlist?list=PLK5e1a2965YW0Swy6-R3i50F5FbtDRiEe BS Decoded: https://www.youtube.com/playlist?list=PLK5e1a2965YWYuC7DEL8Lxl-rhiElowEE Want access to Business Standard’s premium insights? Join our exclusive LinkedIn communities and connect with top voices in the BFSI space—on topics that matter to you! BFSI Circle – https://www.linkedin.com/groups/9867761/ Business Standard Reader's Group – https://www.linkedin.com/groups/5013698/ Hello viewers! Guess what? We're now on WhatsApp Channels! Dive into real-time news updates, insights, and much more. Follow us: https://whatsapp.com/channel/0029Va6cbsSDuMRmPCIgXS2t Subscribe to BS Hindi YouTube Channel: https://www.youtube.com/@bshindinews Download the all-new Business Standard app: https://bit.ly/App-BS Join us: http://www.facebook.com/bsindia http://twitter.com/bsindia https://www.instagram.com/business.standard